Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Nephrol ; 13(2): 117-20, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10228996

ABSTRACT

Twinning and higher-order multiple-gestation pregnancies have become relatively frequent in the current era of assisted reproductive techniques. Vascular interconnections are present in nearly all monochorionic twin placentae, yet hemodynamically significant arteriovenous anastomoses resulting in the feto-fetal transfusion syndrome occur in only 5%-18% of these. When arteriovenous connections through a shared placental cotyledon are present, variable amounts of blood may be transfused from one fetus to the other, and feto-fetal transfusion syndrome may result. While reports of renal failure due to a small non-functioning kidney in the donor infant pre- or postnatally have been published, recoverable renal insufficiency has not been previously delineated in feto-fetal transfusion syndrome. This article describes a case of postnatal transient renal insufficiency in a donor infant from a pair of monozygotic twins.


Subject(s)
Acute Kidney Injury/etiology , Fetofetal Transfusion/complications , Acute Kidney Injury/physiopathology , Creatinine/blood , Female , Humans , Infant, Newborn , Male , Pregnancy , Twins, Monozygotic
2.
Kidney Int ; 47(6): 1528-36, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7643521

ABSTRACT

Detection of circulating antineutrophil cytoplasmic antibodies (ANCA) to the neutrophil serine proteinase, proteinase 3 (PR3), has proven valuable for the diagnosis of Wegener's granulomatosis (WG). However, the importance of these autoantibodies in the pathogenesis of WG remains unknown. It was recently reported that anti-PR3 autoantibodies (PR3-ANCA) from some patients with WG inhibit the proteolytic activity of PR3 and interfere with the inactivation of PR3 by the physiologic inhibitor, alpha 1-proteinase inhibitor (alpha 1-PI). We have studied the effect of PR3-ANCA on the enzymatic activity of PR3 and its correlation with disease activity in patients with WG. We purified IgG from 21 PR3-ANCA positive sera obtained from 17 patients with WG, and determined its effect on the esterolytic and proteolytic activity of purified human PR3 using Boc-Ala-O-Nitrophenyl ester and fluoresceinated-elastin as enzyme substrates. Controls included seven sera containing anti-MPO autoantibodies (MPO-ANCA) from patients with systemic vasculitis and seven ANCA-negative sera obtained from healthy individuals. We found that PR3-ANCA from 9 of the 17 patients significantly inhibited the activity of PR3. There was no correlation between the titers of PR3-ANCA and their inhibitory activity. For one extensively characterized autoantibody, the inhibition reached 70 to 95% at 20-fold molar excess of IgG to enzyme, with an apparent Kiapp of 56.5 microM. This inhibition was non-competitive in nature, and was additive to that produced by alpha 1-PI. A review of the clinical histories of the patients revealed a strong association between active WG and inhibitory autoantibodies.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Autoantibodies/immunology , Granulomatosis with Polyangiitis/physiopathology , Serine Endopeptidases/immunology , Antibodies, Antineutrophil Cytoplasmic , Elastin/metabolism , Esters/metabolism , Female , Granulomatosis with Polyangiitis/immunology , Homeostasis , Humans , Kinetics , Male , Myeloblastin , Serine Endopeptidases/metabolism , alpha 1-Antitrypsin/pharmacology
3.
Genomics ; 9(4): 614-22, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1674725

ABSTRACT

The immunoglobulin heavy chain (IGH) gene cluster and the gene coding for the brain form of the enzyme creatine kinase (CKB) have previously been localized to chromosome 14, at 14q32.3 and 14q32, respectively. Here we report more precise regional localization of these genes by dosage studies using DNA from a child hemizygous for the region from 14q32.32 to 14qter. CKB and IGH are present in a single dose in the proband. Dosage studies in a second patient with a similar but smaller deletion due to a ring chromosome 14 show that CKB is proximal to the IGH cluster. An EcoRI restriction site polymorphism was found with probes for the CKB gene. Linkage analysis of family data indicates that CKB is closely linked to IGH. Linkage analysis also revealed unusually high recombination (beta = 3.2%) between the C delta and C gamma 3 genes of the IGH constant region, which are only 60 kb apart. This finding, in combination with a previous observation of linkage equilibrium in the region, suggests that the C delta-C gamma 3 region contains a recombination hot spot.


Subject(s)
Brain/enzymology , Creatine Kinase/genetics , Genetic Linkage , Immunoglobulin Heavy Chains/genetics , Recombination, Genetic , Cell Line , Chromosome Deletion , Chromosomes, Human, Pair 14 , Female , Humans , Infant, Newborn , Male , Multigene Family , Pedigree , Polymorphism, Restriction Fragment Length
4.
Mol Cell Biol ; 10(4): 1476-83, 1990 Apr.
Article in English | MEDLINE | ID: mdl-2138706

ABSTRACT

Brain creatine kinase is a major enzyme of cellular energy metabolism. It is overexpressed in a wide range of tumor cell lines and is used as a tumor marker. We reported recently that the promoter of the human gene has a strong sequence similarity to the adenovirus E2E promoter. This similarity suggested that the brain creatine kinase gene may be regulated by the viral activator E1a. Experiments reported here showed that both enzyme activity and mRNA levels were induced by the oncogenic products of the E1a region of adenovirus type 5, but unlike the viral E2E promoter, which is induced predominantly by E1a domain 3, brain creatine kinase induction required domains 1 and 2. These domains are important for transformation and for the association of E1a with the retinoblastoma gene product and other cellular proteins. The induction by an oncogene of a cellular gene for energy metabolism may be of significance for the metabolic events that take place after oncogenic activation.


Subject(s)
Adenoviruses, Human/genetics , Cell Transformation, Viral , Creatine Kinase/biosynthesis , DNA-Binding Proteins/metabolism , Oncogene Proteins, Viral/metabolism , Adenovirus Early Proteins , Chromosome Deletion , Creatine Kinase/genetics , Creatine Kinase/metabolism , Energy Metabolism , Enzyme Induction , HeLa Cells/enzymology , Humans , Isoenzymes , Kinetics , Mutation , Oncogene Proteins, Viral/genetics , Restriction Mapping , Transfection
5.
J Biol Chem ; 263(5): 2442-6, 1988 Feb 15.
Article in English | MEDLINE | ID: mdl-2828370

ABSTRACT

There is evidence that the gene for the B isozyme of creatine kinase is regulated during cell differentiation, is under hormonal control, and is activated in a small cell lung carcinoma. In order to investigate further the mechanisms of these processes, the human gene was isolated and the structure of the promoter region was determined. A human DNA fragment of 8 kilobase pairs was shown to encompass the entire coding region and 850 base pairs (bp) of the 5'-flanking sequence. This fragment was transfected into three cell lines and shown to express functional enzyme. The 5'-end of the gene is split by a 230-bp intron that is located 12 bp upstream of the initiator ATG codon. Transcription initiation occurs at a site that is approximately 69 bp upstream of the 5'-end of this intron. The DNA sequence in the region upstream of the 5'-end of the mRNA is suggestive of two superimposed promoters that contain additional sequence elements that are known to regulate expression of other eukaryote genes. The 5'-region also has a remarkable homology to the overlapping promoters of the adenovirus EIIaE gene. These elements collectively form the basis for initial investigations of how this gene is controlled.


Subject(s)
Brain/enzymology , Creatine Kinase/genetics , Amino Acid Sequence , Animals , Base Sequence , Cells, Cultured , DNA Restriction Enzymes/metabolism , Humans , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Transfection
7.
J Biol Chem ; 254(11): 4843-7, 1979 Jun 10.
Article in English | MEDLINE | ID: mdl-35541

ABSTRACT

A method is described which enables one to assay simultaneously the NAD- and NADP-linked reactions of dehydrogenases which can utilize both coenzymes. The method is based on the fact that the thionicotinamide analogs of NADH and NADPH absorb light maximally at 400 nm, a wavelength sufficiently far removed from the absorbance maximum of NADH and NADPH to permit measurements of the simultaneous reduction of NAD+ (or NADP+) and the thionicotinamide analog of NADP+ (or NAD+). Application of the method to glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides reveals differential effects of glucose 6-phosphate concentration on the NAD- and NADP-linked reactions catalyzed by this enzyme which can not be detected by conventional assay procedures and which may have regulatory significance.


Subject(s)
Glucosephosphate Dehydrogenase/analysis , Leuconostoc/enzymology , NADH, NADPH Oxidoreductases/analysis , Kinetics , NAD , NADP
SELECTION OF CITATIONS
SEARCH DETAIL
...